Label: RETAINE PM- mineral oil, white petrolatum ointment

  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated April 9, 2024

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • Active ingredients

    Mineral oil (20%)
    White petrolatum (80%)

  • Purpose

    Eye lubricant

  • Uses

    As a lubricant to prevent further irritaion or to relieve dryness of the eye(s).

  • Warnings

    For use in the eyes only.

  • When using this product

    ● do not touch tip of container to any surface to avoid contamination.
    ● replace cap after use.

  • Stop use and ask a doctor if

    ● you experience eye pain, changes in vision, continued redness or irritation of the eye.
    ● the condition worsens or persists for more than 72 hours.

  • Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center immediately.

  • Directions

    ● Pull down the lower lid of the affected eye(s).
    ● Apply a small amount (1/4 inch) of ointment to the inside of the eyelid.

  • Inactive Ingredients

    None

  • Other information

    ● Do not use if cap breakaway seal is broken or missing.
    ● Store between 15°-30°C (59°-86°F).
    ● Keep this carton for full product information.

  • Questions?

    ☎ Call
    (800) 233-5469 M-F
    8:30AM-5:00PM CST
    or visit retainebrand.com

  •        

  • Package label. Principal Display Panel

    Retaine PM
    Retaine PM
    Retaine PM

  • INGREDIENTS AND APPEARANCE
    RETAINE PM 
    mineral oil, white petrolatum ointment
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54799-893
    Route of AdministrationOPHTHALMIC
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Mineral Oil (UNII: T5L8T28FGP) (Mineral Oil - UNII:T5L8T28FGP, Mineral Oil - UNII:T5L8T28FGP) Mineral Oil200 mg  in 1 g
    Petrolatum (UNII: 4T6H12BN9U) (Petrolatum - UNII:4T6H12BN9U, Petrolatum - UNII:4T6H12BN9U) Petrolatum800 mg  in 1 g
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:54799-893-055 g in 1 TUBE; Type 0: Not a Combination Product09/02/2013
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01809/02/2013
    Labeler - OCuSOFT, Inc. (174939207)
    Registrant - OCuSOFT, Inc. (174939207)
    Establishment
    NameAddressID/FEIBusiness Operations
    Galentic Pharma (India) Private Limited650970176manufacture(54799-893)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!